Clinical trials: Chronic Hepatitis B - Antiviral Drug Resistance - Hepatitis B Virus (HBV) Infection, open to volunteers
- Condition Chronic Hepatitis B - Antiviral Drug Resistance - Hepatitis B Virus (HBV) Infection
- Status Open to volunteers
Chronic Hepatitis B - Antiviral Drug Resistance - Hepatitis B Virus (HBV) Infection
Prevalence and Risk Factors of Antiviral Resistance in Egyptian HBV Patients
This study aims to determine the prevalence of antiviral drug resistance among Egyptian patients with chronic hepatitis B virus (HBV) infection and to identify the associated demographic, clinical, and virological risk factors.
- Trial name
- PRARE-CHB (NCT07274345)
- Volunteers
- 2,000 people
- Sponsor
- Amira Mohamed Zidan